24 May 2013
Keywords: csl, profit, warning, australia, largest, biotechnology, company
Article | 25 October 1999
Australia's largest biotechnology company by market value, CSL, hasforecast lower profits for the fiscal year to June 2000 because of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 October 1999
27 September 1999
23 May 2013
© 2013 thepharmaletter.com